8th International Congress Research Articles

"8th International Congress on Creation in the Light of Science" at Üsküdar University!

"8th International Congress on Creation in the Light of Science" at Üsküdar University!

The XVI International Congress of Acarology (1–5 December 2022, Auckland, New Zealand): A full report

The 16th International Congress of Acarology was successfully conducted from December 1 to 5, 2022, at the Owen G. Glenn Building, The University of Auckland, in Auckland, New Zealand. The event saw a total of 259 attendees from 32 different countries or regions, with two-thirds of them participating virtually. Besides the opening and closing ceremonies, the congress included (1) five plenary keynote presentations (one each day), (2) 52 invited presentations across eight symposia, 93 presentations in 10 subject sections, and 19 poster flash presentations in two parallel sessions, and (3) 16 poster presentations. This congress was the first of its kind to publish the proceedings before the event began and to provide video recordings for the participants and potentially the wider community.

16th International congress on antiphospholipid antibodies task force report on antiphospholipid syndrome laboratory diagnostics and trends.

Classification criteria for antiphospholipid syndrome (APS) require IgG or IgM isotypes of the anticardiolipin (aCL) antibodies, anti-β2 glycoprotein I (anti-β2GPI) antibodies, and/or the lupus anticoagulant (LA) to satisfy the laboratory disease definition. Over the past 20 years, non-criteria antiphospholipid antibodies (aPL) directed to other proteins of the coagulation cascade (i.e. prothrombin and/or phosphatidylserine-prothrombin complex) or to some domains of β2GPI have been proposed. This task force concentrated and reviewed the literature on data including aPS/PT, antibodies to domain 4/5 of β2GPI and the newly described antibodies to protein/HLA-DR complex. In addition, we discussed testing of LA in the 'new' oral anticoagulants' era and the value of triple positivity in the risk assessment of aPL. The conclusions were presented at a special session during the 16th International Congress on aPL, Manchester, UK, September 2019.

EEM2023 - an event focused on current issues concerning sustainable development, environmental protection and process industry

The 8th International Congress “Engineering, Environment and Materials in Process Industry” – EEM2023 is organized by the Faculty of Technology Zvornik, University of East Sarajevo. The focus of this event is a comprehensive and multidisciplinary approach to current issues concerning sustainable development, environment protection and process industry, with the aim of developing new projects and exploiting new technologies for sustainable applications. The congress aims to help researchers, scientists and academia to discover new directions in research, development and education, by providing an overview of the state-of-the art findings and trends in the field and offering a platform for the exchange of ideas.

8th International Congress of Clinical and Health Psychology in Children and Adolescents

8th International Congress of Clinical and Health Psychology in Children and Adolescents

8th International Congress of Research in Retina and Vision

xxx

MONTEVIDEO DECLARATION 2020

Resulting from the 8th International Congress, 6th Latin American Conference and 2nd Uruguayan Meeting of Person Centered Medicine carried out as a virtual event from Montevideo, Uruguay, from December 18 to 20, 2020. Organized by the Latin American Network of Medicine Centered on the Person (RLMCP), the International College of Person Centered Medicine (ICPCM) and the Representation in Uruguay of the Pan American Health Organization (PAHO / WHO), under the auspices of the Latin American Association of National Academies of Medicine, the Peruvian and Uruguayan Associations of Person Centered Medicine, and the National University of San Marcos (particularly the Hipólito Unanue Chair of Person Centered Medicine and the Health Ethics Institute of the San Fernando School of Medicine).

Investigation of Digital Game Addiction and Attitudes Towards Sports in Adolescent Individuals

Aim: This study aimed to examine digital game addiction and attitudes towards sports in adolescents. Method: The screening model was used in our research. After giving preliminary information about the questionnaire to the participants, a total of 191 volunteers, 113 (59.5%) females and 77 (40.5%) males participated in the study voluntarily. In the research, the 'Digital Game Addiction Scale (DGAS-7) and the 'Sports Attitude Scale ' (5-point Likert Type) consisting of 22 items were used as data collection tools. The research data were analyzed with the SPSS 22.0 package program and the margin of error was taken as p<0.05. Results: When the results were examined, it was seen that 59.5% of the participants were women, 40.5% were men, and 45.8% participated in the exercise activity. At the same time, it was understood that the total scores of psychosocial development, mental development and attitude towards sports, which were sub-dimensions of the sports attitude scale, of the participants who exercise had higher scores than the participants who did not exercise. In this context, it can be said that the attitudes of the participants who exercise were more meaningful. Conclusion: As a result, young adult individuals who were connected to games may have difficulties in fulfilling their daily responsibilities and may cause mental and cognitive disorders as a result of establishing a connection between real life and the virtual world, which can negatively affect their academic achievement levels. Moreover, individuals should be encouraged to participate in sports, because it was thought to have a positive effect on the mental and physical development of young adults. Keywords: Adolescent, Sports and Digital Game This Research Was Present at as Oral Presentation the 8th International Congress on Science, Culture and Sports

Innovations in Arts-Based Research: ABR Provocations From the 16th International Congress of Qualitative Research

Innovations in Arts-Based Research: ABR Provocations From the 16th International Congress of Qualitative Research

Substantive report of the 8th International Congress of Social Inclusion

x

(Invited) Transdermal Alcohol Monitoring with a Printed Amperometric Sensor

(Invited) Transdermal Alcohol Monitoring with a Printed Amperometric Sensor

16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome.

The objectives of the 16th International Congress on Antiphospholipid Antibodies (aPL) Task Force on Clinical Manifestations of Antiphospholipid Syndrome (APS) were to critically analyze: a) the definition of "APS"; b) the current knowledge on non-traditional manifestations associated with aPL; and c) the risk stratification strategies in aPL-positive patients. The quality of evidence was assessed by the GRADE system. The task force concluded that: a) APS does not have a uniform definition given the heterogeneity of the clinical presentations and different aPL profiles; b) current literature supports the role for aPL testing in cases of thrombocytopenia and recurrent cardiac events but are limited by vast heterogeneity, providing an overall low-to-very low level of evidence; and c) risk stratification strategies in aPL-positive patients, such as aPL-Score and Global APS Score, can be useful in clinical practice. International multicenter studies are still highly needed to improve the quality of available evidence and consequently the strength of future recommendations.

Detection of cancer metastasis: past, present and future.

The clinical importance of metastatic spread of cancer has been recognized for centuries, and melanoma has loomed large in historical descriptions of metastases, as well as the numerous mechanistic theories espoused. The "fatal black tumor" described by Hippocrates in 5000 BC that was later termed "melanose" by Rene Laennec in 1804 was recognized to have the propensity to metastasize by William Norris in 1820. And while the prognosis of melanoma was uniformly acknowledged to be dire, Samuel Cooper described surgical removal as having the potential to improve prognosis. Subsequent to this, in 1898 Herbert Snow was the first to recognize the potential clinical benefit of removing clinically normal lymph nodes at the time of initial cancer surgery. In describing "anticipatory gland excision," he noted that "it is essential to remove, whenever possible, those lymph glands which first receive the infective protoplasm, and bar its entrance into the blood, before they have undergone increase in bulk". This revolutionary concept marked the beginning of a debate that rages today: are regional lymph nodes the first stop for metastases ("incubator" hypothesis) or does their involvement serve as an indicator of aggressive disease with inherent metastatic potential ("marker" hypothesis). Is there a better way to improve prediction of disease outcome? This article attempts to address some of the resultant questions that were the subject of the session "Novel Frontiers in the Diagnosis of Cancer" at the 8th International Congress on Cancer Metastases, held in San Francisco, CA in October 2019. Some of these questions addressed include the significance of sentinel node metastasis in melanoma, and the optimal method for their pathologic analysis. The finding of circulating tumor cells in the blood may potentially supplant surgical techniques for detection of metastatic disease, and we are beginning to perfect techniques for their detection, understand how to apply the findings clinically, and develop clinical followup treatment algorithms based on these results. Finally, we will discuss the revolutionary field of machine learning and its applications in cancer diagnosis. Computer-based learning algorithms have the potential to improve efficiency and diagnostic accuracy of pathology, and can be used to develop novel predictors of prognosis, but significant challenges remain. This review will thus encompass latest concepts in the detection of cancer metastasis via the lymphatic system, the circulatory system, and the role of computers in enhancing our knowledge in this field.

Secondary lymphedema from cancer therapy.

This manuscript is a summary of findings focusing on various aspects of secondary lymphedema specifically as a sequelae of treatment for cancer. The topic was addressed at a session held during the 8th International Congress on Cancer Metastasis that was unique a for the inclusion of patients with lymphedema and therapists joining physicians, healthcare professionals, and researchers in an effort to give an overview of secondary lymphedema following cancer therapy as well as highlighting the unknowns in the field. Lymphedema is defined and both diagnosis and incidence of cancer-related lymphedema are explored. Further, exploration of imaging options for lymphedema and information on the genetic research for patients with cancer-related secondary lymphedema are presented. Patient education and early detection methods are then explored followed by conservative treatment. Finally, an examination of surgical treatment methods available for patients with lymphedema is covered. Overall, this manuscript presents valuable information and updates for those not familiar with incidence, diagnosis, early detection, and rehabilitation of patients with cancer-related secondary lymphedema.

Selected Lectures of the 16th International Congress on Neonatology and Pediatrics, On Demand; Cagliari (Italy); November 20th-December 31st, 2020

Selected Lectures of the 16th International Congress on Neonatology and Pediatrics, On Demand; Cagliari (Italy); November 20th-December 31st, 2020

16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends.

Antiphospholipid syndrome (APS), an acquired autoimmune thrombophilia, is characterised by thrombosis and/or pregnancy morbidity in association with persistent antiphospholipid antibodies. The 16th International Congress on Antiphospholipid Antibodies Task Force on APS Treatment Trends reviewed the current status with regard to existing and novel treatment trends for APS, which is the focus of this Task Force report. The report addresses current treatments and developments since the last report, on the use of direct oral anticoagulants in patients with APS, antiplatelet agents, adjunctive therapies (hydroxychloroquine, statins and vitamin D), targeted treatment including rituximab, belimumab, and anti-TNF agents, complement inhibition and drugs based on peptides of beta-2-glycoprotein I. In addition, the report summarises potential new players, including coenzyme Q10, adenosine receptor agonists and adenosine potentiation. In each case, the report provides recommendations for clinicians, based on the current state of the art, and suggests a clinical research agenda. The initiation and development of appropriate clinical studies requires a focus on devising suitable outcome measures, including a disease activity index, an optimal damage index, and a specific quality of life index.

16th International Congress on Antiphospholipid Antibodies Task Force Report on Obstetric Antiphospholipid Syndrome.

Obstetric antiphospholipid syndrome (APS) remains a clinical challenge for practitioners, with several controversial points that have not been answered so far. This Obstetric APS Task Force met on the 16th International Congress on Antiphospholipid Antibodies in Manchester, England, to discuss about treatment, diagnostic and clinical aspects of the disease. This report will address evidence-based medicine related to obstetric APS, including limitations on our current management, the relationship between antibodies against domain 1 of β2GPI and obstetric morbidity, hydroxychloroquine use in patients with obstetric APS and factors associated with thrombosis after obstetric APS. Finally, future directions for better understanding this complex condition are also reported by the Task Force coordinators.

16th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome.

The Task Force on Catastrophic Antiphospholipid Syndrome (CAPS) met again on occasion of the 16th International Congress on Antiphospholipid Antibodies (aPL) that was held in Manchester, England, in September 2019. Its aims were to assess the up-to-date knowledge on pathogenesis, clinical and laboratory features, diagnosis and classification, precipitating factors, and treatment of CAPS. This article summarizes the main aspects that were presented during the Task Force meeting at that Congress.

Beyond current concepts in anti-phospholipid syndrome: The 16th International Congress on Anti-phospholipid Antibodies (ICAPA) in Manchester

To assess the mean platelet volume (MPV), platelet-to-lymphocyte ratio (PLR), the neutrophil-to-lymphocyte ratio (NLR) and the MPV-to-lymphocyte ratio, and to test them according to the clinical/serological status, shift through time and other comorbidities in APS.We included 96 primary APS patients according to the Sydney classification criteria and/or patients with thrombocytopenia and/or autoimmune hemolytic anemia who also fulfilled the serological criteria. We tested aCL, anti-β2GP-I and aPS/PT antibodies and LA. We first registered the MPV and the aforementioned ratios within at least 6 months after an event of thrombosis or thrombocytopenia/AIHA (baseline determination), and during thrombosis/thrombocytopenia/AIHA onset when available (acute event).A lower baseline MPV and a higher PLR characterized the thrombotic group (n = 74). The AUC for baseline PLR was 0.82 (p < 0.001): SE of 69%, SP 91%, PPV 96%, NPV 74%, LR+ 13.67 and LR- 0.19. During the acute event, both variables increased. The thrombocytopenic group (n = 66) had a higher baseline MPV and a lower PLR, and during an acute event the PLR decreased more deeply. The AUC for MPV was 0.64 (p = 0.02): SE 44%, SP 92%, PPV 86%, NPV 40%, LR+ 3.3 and LR- 0.85. These findings were not related with the aPL antibody profile status, titers or comorbidities.Basal MPV and PLR might help to identify APS patients according to their thrombotic or thrombocytopenic phenotype. These variables change during the acute events and might be the reflex of physiopathological or compensatory mechanisms in APS.

Meeting report of the 16th international congress of radiation research and the 12th international symposium on chromosomal aberrations

Meeting report of the 16th international congress of radiation research and the 12th international symposium on chromosomal aberrations